Dimera Incorporated is a specialized west coast biotechnology company dedicated to discovering novel medical concepts to address the leading cause of death and dysfunction, heart and blood vessel disease. They focus on developing safe and effective medicines to reduce the risk of heart disease and blood vessel dysfunction by treating causes rather than symptoms.
With their rational approach, Dimera has progressed through FDA clinical trials to develop DP9, the first Heart Drug for Women, which promises to solve the unmet need revealed by the Women's Health Initiative clinical trial. Their research highlights the differences between heart disease in women and men, making them a pioneer in addressing the critical unmet need for heart and cardiovascular dysfunction in women.
Generated from the website